Lundbeck
HLUN-B.CO
HK$33.76
Share price
2.43%
Change (1 day)
-9.88%
Change (1 year)
Categories
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.
EPS for Lundbeck (HLUN-B.CO)
EPS in 2023 (TTM): HK$2.77
According to Lundbeck 's latest financial reports the company's current EPS (TTM) is HK$2.74. In 2022 the company made an earnings per share (EPS) of HK$2.09 a decrease over its 2021 EPS that were of HK$4.69.
EPS history for Lundbeck from 2009 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | HK$2.77 | 32.94% |
| 2022 | HK$2.09 | -55.47% |
| 2021 | HK$4.69 | -51.83% |
| 2020 | HK$9.73 | -28.01% |
| 2019 | HK$13.51 | -44.08% |
| 2018 | HK$24.17 | 51.94% |
| 2017 | HK$15.90 | 126.64% |
| 2016 | HK$7.02 | -120.84% |
| 2015 | -HK$33.67 | 5622.18% |
| 2014 | -HK$0.59 | -110.03% |
| 2013 | HK$5.87 | -28.08% |
| 2012 | HK$8.16 | -52.1% |
| 2011 | HK$17.02 | -1.31% |
| 2010 | HK$17.25 | 15.61% |
| 2009 | HK$14.92 |